Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.321,54
-0,41%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Nicox SA (NXOA) Nicox SA (NXOA) Notizie

Nicox SA

NXOA
0,00
0,00 (0,00%)
- - Chiuso
Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
04/12/202407:30UKREGNicox annonce la première vente commerciale de ZERVIATE en..
04/12/202407:30UKREGNicox Announces First Commercial Sale of ZERVIATE in China..
02/12/202407:30UKREGNicox : Recrutement de patients achevé plus tôt que prévu en..
02/12/202407:30UKREGNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in..
19/11/202407:30UKREGNicox annonce la publication de la partie adaptive de..
19/11/202407:30UKREGNicox Announces Publication of the Adaptive Design Period of..
17/10/202407:30UKREGNicox Provides Third Quarter 2024 update and First Half 2024..
17/10/202407:30UKREGNicox : Point financier sur le troisième trimestre 2024 et..
14/10/202407:30UKREGNicox et Soleus signent un accord de financement de 16,5..
14/10/202407:30UKREGNicox and Soleus Sign $16.5 million Royalty and Equity..
23/9/202407:30UKREGNicox and Glaukos Sign Exclusive NCX 1728 Research and..
23/9/202407:30UKREGNicox et Glaukos signent un accord exclusif de recherche..
18/9/202407:30UKREGNicox annonce l’approbation de ZERVIATE en Chine
18/9/202407:30UKREGNicox Announces Approval of ZERVIATE in China
04/9/202407:30UKREGNicox Appoints Christine Placet to Board of Directors;..
04/9/202407:30UKREGNicox nomme Christine Placet administrateur ; Michele Garufi..
25/7/202407:30UKREGNicox Announces Recruitment of Last Patient in U.S. in..
25/7/202407:30UKREGNicox : Recrutement du dernier patient aux Etats- Unis dans..
19/7/202407:30UKREGNicox : Participation aux prochaines conférences
19/7/202407:30UKREGNicox announces attendance at upcoming conferences
18/7/202407:30UKREGNicox : Résumé financier du deuxième trimestre 2024
18/7/202407:30UKREGNicox Provides Second Quarter 2024 Update
16/7/202407:30UKREGNicox nomme le dirigeant biotech expérimenté Damian Marron..
16/7/202407:30UKREGNicox appoints experienced biotech leader Damian Marron as..
27/6/202417:30GLOBENicox : Assemblée Générale Ordinaire 2024
19/6/202407:30GLOBENicox annonce le succès de son augmentation de capital avec..
03/6/202407:30GLOBENumber of voting rights as of May 31, 2024
31/5/202407:30GLOBENicox annonce l’organisation d’un webcast pour ses..
30/5/202407:30GLOBENicox annonce le lancement d’une augmentation de capital..
24/5/202407:30GLOBENicox: 2024 Ordinary Shareholder Meeting to be held on June..
06/5/202417:46GLOBENicox’s Ordinary and Extraordinary Shareholders' Meeting on..
02/5/202417:45GLOBENumber of voting rights as of April 30, 2024
24/4/202407:30GLOBENicox: Second notice of the Ordinary and Extraordinary..
22/4/202407:30GLOBENicox Provides First Quarter 2024 Update and Full Year 2023..
09/4/202417:30GLOBENicox: 2024 Ordinary and Extraordinary Shareholder Meeting
02/4/202417:45GLOBENombre de droits de vote au 31 mars 2024
22/3/202407:30GLOBENicox - Lettre aux Actionnaires
20/3/202407:30GLOBENicox : Publication de résultats de l’étude de phase 3 Mont..
13/3/202407:30GLOBENicox Updates on Corporate, Pipeline and Financing..
05/3/202407:30GLOBENicox : Présentation de données sur le NCX 470 au Congrès..
01/3/202417:45GLOBENumber of voting rights as of February 29, 2024
28/2/202407:30GLOBEGavin Spencer, dirigeant expérimenté du secteur de la..
08/2/202407:30GLOBENicox : Contrat de licence avec la société Kowa pour le..
06/2/202407:30GLOBENicox announces presentations at the upcoming Association..
01/2/202417:45GLOBENumber of votings rights as of January 31 2024
31/1/202407:30GLOBENicox Receives Confirmation of 5-year Patent Term Extension..
25/1/202407:30GLOBENicox : Résumé financier et point d’activité du quatrième..
Apertura: Min: Max:
Chiusura:

La tua Cronologia

TG
NXOA
Nicox
BIT
EPRE
Exchange Traded
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network